Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $282.20 | Total: $1,411.00 |
| 1 | 10 | $239.04 | Total: $2,390.40 |
| 1 | 25 | $202.52 | Total: $5,063.00 |
| 1 | 50 | $172.64 | Total: $8,632.00 |
| 1 | 100 | $149.40 | Total: $14,940.01 |
Overview
Pegamotecan (PEG-camptothecin) is a topoisomerase I (TOP1) inhibitor with anticancer activity, and it is used in the treatment of esophageal, non-small cell lung and pancreatic cancers.
Chemical Properties
| Molecular Formula | C52H48N6O14 |
| Molecular Weight | 980.984 |
| CAS Numbers | 581079-18-7 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | CC[C@@]1(OC(=O)[C@H](C)NC(=O)COCCOCC(=O)N[C@@H](C)C(=O)O[C@]2(CC)C(=O)OCc3c2cc2-c4nc5ccccc5cc4Cn2c3=O)C(=O)OCc2c1cc1-c3nc4ccccc4cc3Cn1c2=O |
Storage and Handling
0C Short Term, -20C Long Term
References
Chuang CH, et al. Development of pH-Sensitive Cationic PEGylated Solid Lipid Nanoparticles for Selective Cancer-Targeted Therapy. J Biomed Nanotechnol. 2017 Feb;13[2] 192-03.